Format

Send to

Choose Destination
Oncotarget. 2018 Feb 7;9(18):14354-14365. doi: 10.18632/oncotarget.24436. eCollection 2018 Mar 6.

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer.

Kim WT#1,2,3, Kim YH#1, Jeong P1, Seo SP1,2, Kang HW1,2, Kim YJ1,2, Yun SJ1,2, Lee SC1,2, Moon SK4, Choi YH5, Lee GT3, Kim IY3, Kim WJ1,2.

Author information

1
Department of Urology, Chungbuk National University College of Medicine, Cheongju, Chungbuk, South Korea.
2
Department of Urology, Chungbuk National University Hospital, Cheongju, Chungbuk, South Korea.
3
Section of Urological Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
4
School of Food Science and Technology, Chung-Ang University, Anseong, South Korea.
5
Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan, South Korea.
#
Contributed equally

Abstract

Background:

There is growing interest in developing new non-invasive diagnostic tools for bladder cancer (BC) that have better sensitivity and specificity than cystoscopy and cytology. This study examined the value of urinary cell-free nucleic acid (NA) as a diagnostic marker for BC.

Material and methods:

A total of 81 patients (74 BC and 7 normal controls) were used for a tissue set, and 212 patients (92 BC and 120 normal controls) were used as a urine set. Expression of tissue mRNA and urinary cell-free NAs was then examined.

Results:

Four candidate genes were top-ranked in the tissue microarray. Expression levels of two of these (IQGAP3 and TOP2A) in BC tissue and urine samples from BC patients were significantly higher than those in samples from the control groups. Binary logistic regression analysis of cell-free NA levels in urine samples revealed that IQGAP3 was significantly associated with BC: PicoGreen-adjusted odds ratio (OR), 3.434; confidence interval (CI), 2.999-4.180; P<0.001; RiboGreen-adjusted OR, 2.242; CI, 1.793-2.840; P<0.001. Further analysis of IQGAP3 urinary cell-free NAs with respect to tumor invasiveness and grade also yielded a high AUC, suggesting that IQGAP3 can discriminate between BC patients and non-cancer patients with hematuria.

Conclusions:

Levels of IQGAP3 urinary cell-free NA in BC patients were significantly higher than those in normal controls or patients with hematuria. High levels of IQGAP3 urinary cell-free NA also reflected high expression in BC tissues. Therefore, IQGAP3 urinary cell-free NA may be a complementary diagnostic biomarker for BC.

KEYWORDS:

biomarkers; nucleic acids; urinary bladder neoplasms; urine

Conflict of interest statement

CONFLICTS OF INTEREST The authors have no conflicts of interest to declare.

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center